Table 2 Weight and weight score of each indicator for alone and combined
Classification | Outcome indicators | Weight | Best | Worst | Relative weights | Weight Sore | |
|---|---|---|---|---|---|---|---|
Alone | Combine | ||||||
Benefit | Effective/% | 80 | 5 | 1 | 9.60% | 3.456 | 6.528 |
Morning stiffness/min | 80 | ‒13 | 0 | 9.60% | 2.784 | 7.776 | |
TJC | 100 | ‒2 | 0 | 12% | 5.76 | 4.92 | |
SJC | 100 | ‒3 | 0 | 12% | 6.36 | 5.04 | |
ESR/mm/h | 40 | ‒10 | 0 | 4.80% | 2.496 | 3.36 | |
RF/IU/ml | 60 | ‒17 | 0 | 7.20% | 1.008 | 4.32 | |
CRP/mg/L | 40 | ‒7 | 0 | 4.80% | 1.824 | 3.504 | |
Benefit Total | Â | Â | Â | Â | 60% | 23.4 | 35.4 |
Risk | Adverse effects Rate /% | 80 | 0 | 1 | 8.40% | 5.124 | 3.192 |
Gastrointestinal reaction /% | 40 | 0 | 1 | 4.20% | 2.268 | 1.638 | |
Liver damage /% | 100 | 0 | 1 | 10.50% | 8.085 | 7.035 | |
Leucopenia /% | 100 | 0 | 1 | 10.50% | 5.145 | 5.775 | |
Skin lesions /% | 40 | 0 | 1 | 4.20% | 0 | 0 | |
Others/% | 20 | 0 | 1 | 2.10% | 1.827 | 1.113 | |
Risk Total | Â | Â | Â | Â | 40% | 22.4 | 17.2 |
Overall Total | Â | Â | Â | Â | 100% | 46 | 53 |